Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 280-287

  Cheng, Hsinlin T ^a   Dauch, Jacqueline R ^a   Hayes, John M ^a   Yanik, Brandon M ^b   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Diabetic pain; Intraepidermal nerve fibers; Mechanical allodynia; Nerve growth factor; Peptidergic nerve fibers; Type 2 diabetes

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; PROTEIN ANTIBODY; PROTEIN GENE PRODUCT 9.5; PROTEIN GENE PRODUCT 9.5 ANTIBODY; PROTEIN TYROSINE KINASE A; SUBSTANCE P; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTRAEPIDERMAL NERVE FIBER DENSITY; MALE; MOUSE; NERVE FIBER; NEUROTROPISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAINFUL DIABETIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; HYPERALGESIA; MALE; MICE; NERVE FIBERS; NERVE GROWTH FACTOR; OBESITY; PHYSICAL STIMULATION; SIGNAL TRANSDUCTION;

EID: 81955160745     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.08.011     Document Type: Article

References (42)

1. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., Malik R.A., Maser R.E., Sosenko J.M., Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962.
2. Catalan V., Gomez-Ambrosi J., Ramirez B., Rotellar F., Pastor C., Silva C., Rodriguez A., Gil M.J., Cienfuegos J.A., Fruhbeck G. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes. Surg. 2007, 17:1464-1474.
3. Cheng H.T., Dauch J.R., Hayes J.M., Hong Y., Feldman E.L. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J. Neuropathol. Exp. Neurol. 2009, 68:1229-1243.
4. Cheng H.T., Dauch J.R., Oh S.S., Hayes J.M., Hong Y., Feldman E.L. p38 mediates mechanical allodynia in a mouse model of type 2 diabetes. Mol. Pain. 2010, 6:28.
5. Christianson J.A., Riekhof J.T., Wright D.E. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 2003, 179:188-199.
6. Christianson J.A., Ryals J.M., Johnson M.S., Dobrowsky R.T., Wright D.E. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 2007, 145:303-313.
7. Diamond J., Foerster A. Recovery of sensory function in skin deprived of its innervation by lesion of the peripheral nerve. Exp. Neurol. 1992, 115:100-103.
8. Dib-Hajj S.D., Black J.A., Cummins T.R., Kenney A.M., Kocsis J.D., Waxman S.G. Rescue of alpha-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo. J. Neurophysiol. 1998, 79:2668-2676.
9. Diemel L.T., Cai F., Anand P., Warner G., Kopelman P.G., Fernyhough P., Tomlinson D.R. Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diabet. Med. 1999, 16:113-118.
10. Dworkin R.H., Turk D.C., Farrar J.T., Haythornthwaite J.A., Jensen M.P., Katz N.P., Kerns R.D., Stucki G., Allen R.R., Bellamy N., Carr D.B., Chandler J., Cowan P., Dionne R., Galer B.S., Hertz S., Jadad A.R., Kramer L.D., Manning D.C., Martin S., McCormick C.G., McDermott M.P., McGrath P., Quessy S., Rappaport B.A., Robbins W., Robinson J.P., Rothman M., Royal M.A., Simon L., Stauffer J.W., Stein W., Tollett J., Wernicke J., Witter J. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005, 113:9-19.
11. Dworkin R.H., Jensen M.P., Gammaitoni A.R., Olaleye D.O., Galer B.S. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain. J. Pain 2007, 8:118-126.
12. English A.W., Meador W., Carrasco D.I. Neurotrophin-4/5 is required for the early growth of regenerating axons in peripheral nerves. Eur. J. Neurosci. 2005, 21:2624-2634.
13. Feldman E.L., Stevens M.J., Russell J.W., Peltier A., Inzucchi S., Porte J.D., Sherwin R.S., Baron A. Somatosensory neuropathy. The Diabetes Mellitus Manual 2005, vol. 6th:366-384. McGraw-Hill.
14. Galer B.S., Gianas A., Jensen M.P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res. Clin. Pract. 2000, 47:123-128.
15. Griffin J.W., Pan B., Polley M.A., Hoffman P.N., Farah M.H. Measuring nerve regeneration in the mouse. Exp. Neurol. 2010, 223:60-71.
16. Holland N.R., Stocks A., Hauer P., Cornblath D.R., Griffin J.W., McArthur J.C. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997, 48:708-711.
17. Huang C., Borchers C.H., Schaller M.D., Jacobson K. Phosphorylation of paxillin by p38MAPK is involved in the neurite extension of PC-12 cells. J. Cell Biol. 2004, 164:593-602.
18. Jensen M.P., Dworkin R.H., Gammaitoni A.R., Olaleye D.O., Oleka N., Galer B.S. Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?. J. Pain 2006, 7:644-653.
19. Ji R.R., Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol. Dis. 2001, 8:1-10.
20. Johnson M.S., Ryals J.M., Wright D.E. Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy. Pain 2008, 140:35-47.
21. Kano Y., Nohno T., Shimada K., Nakagiri S., Hiragami F., Kawamura K., Motoda H., Numata K., Murai H., Koike Y., Inoue S., Miyamoto K. Osmotic shock-induced neurite extension via activation of p38 mitogen-activated protein kinase and CREB. Brain Res. 2007, 1154:1-7.
22. Karanth S.S., Springall D.R., Francavilla S., Mirrlees D.J., Polak J.M. Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats. Histochemistry 1990, 94:659-666.
23. Karanth S.S., Springall D.R., Kuhn D.M., Levene M.M., Polak J.M. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene product 9.5 in man and commonly employed laboratory animals. Am. J. Anat. 1991, 191:369-383.
24. Kennedy W.R., Wendelschafer-Crabb G., Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996, 47:1042-1048.
25. Lauria G., Cornblath D.R., Johansson O., McArthur J.C., Mellgren S.I., Nolano M., Rosenberg N., Sommer C. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol. 2005, 12:747-758.
26. Levy D.M., Terenghi G., Gu X.H., Abraham R.R., Springall D.R., Polak J.M. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 1992, 35:889-897.
27. Nixon B.J., Doucette R., Jackson P.C., Diamond J. Impulse activity evokes precocious sprouting of nociceptive nerves into denervated skin. Somatosens Res. 1984, 2:97-126.
28. Pezet S., McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 2006, 29:507-538.
29. Polydefkis M., Hauer P., Griffin J.W., McArthur J.C. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol. Ther. 2001, 3:23-28.
30. Properzi G., Francavilla S., Poccia G., Aloisi P., Gu X.H., Terenghi G., Polak J.M. Early increase precedes a depletion of VIP and PGP-9.5 in the skin of insulin-dependent diabetics-correlation between quantitative immunohistochemistry and clinical assessment of peripheral neuropathy. J. Pathol. 1993, 169:269-277.
31. Schafers M., Geis C., Brors D., Yaksh T.L., Sommer C. Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J. Neurosci. 2002, 22:536-545.
32. Schafers M., Geis C., Svensson C.I., Luo Z.D., Sommer C. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur. J. Neurosci. 2003, 17:791-804.
33. Shun C.T., Chang Y.C., Wu H.P., Hsieh S.C., Lin W.M., Lin Y.H., Tai T.Y., Hsieh S.T. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004, 127:1593-1605.
34. Sorensen L., Molyneaux L., Yue D.K. The level of small nerve fiber dysfunction does not predict pain in diabetic Neuropathy: a study using quantitative sensory testing. Clin. J. Pain 2006, 22:261-265.
35. Sorensen L., Molyneaux L., Yue D.K. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006, 29:883-887.
36. Sullivan K.A., Hayes J.M., Wiggin T.D., Backus C., Su Oh S., Lentz S.I., Brosius F., Feldman E.L. Mouse models of diabetic neuropathy. Neurobiol. Dis. 2007, 28:276-285.
37. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
38. Wild K.D., Bian D., Zhu D., Davis J., Bannon A.W., Zhang T.J., Louis J.C. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J. Pharmacol. Exp. Ther. 2007, 322:282-287.
39. Wright D.E., Johnson M.S., Arnett M.G., Smittkamp S.E., Ryals J.M. Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db/db) mice. J. Peripher. Nerv. Syst. 2007, 12:250-261.
40. Yasuda H., Terada M., Maeda K., Kogawa S., Sanada M., Haneda M., Kashiwagi A., Kikkawa R. Diabetic neuropathy and nerve regeneration. Prog. Neurobiol. 2003, 69:229-285.
41. Zandecki M., Vanden Berghe P., Depoortere I., Geboes K., Peeters T., Janssens J., Tack J. Characterization of myenteric neuropathy in the jejunum of spontaneously diabetic BB-rats. Neurogastroenterol. Motil. 2008, 20:818-828.
42. Ziegler D., Rathmann W., Dickhaus T., Meisinger C., Mielck A. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009, 10:393-400.